Treatment of pruritus caused by cholestasis with opioid antagonists
Jones, E.A.; Zylicz, Z.
Journal of Palliative Medicine 8(6): 1290-1294
2005
ISSN/ISBN: 1096-6218 PMID: 16351546 DOI: 10.1089/jpm.2005.8.1290
Accession: 050845716
Full Text Article emailed within 0-6 h: $19.90
Related References
Tandon, P.; Rowe, B.H.; Vandermeer, B.; Bain, V.G. 2007: The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus American Journal of Gastroenterology 102(7): 1528-1536Jones, E.A. 2002: Trials of opiate antagonists for the pruritus of cholestasis: primary efficacy endpoints and opioid withdrawal-like reactions Journal of Hepatology 37(6): 863-865
Friedman, J.D.; Dello Buono, F.A. 2001: Opioid antagonists in the treatment of opioid-induced constipation and pruritus Annals of PharmacoTherapy 35(1): 85-91
Heathcote, E.Jenny. 2007: Is rifampin a safe and effective treatment for pruritus caused by chronic cholestasis? Nature Clinical Practice. Gastroenterology and Hepatology 4(4): 200-201
Rashid, S.; Trivedi, D.D.; Al-Shathir, M.; Moulton, M.; Baumrucker, S.J. 2018: Is there a Role for 5-HT3 Receptor Antagonists in the Treatment of Opioid-Induced Pruritus? American Journal of Hospice and Palliative Care 35(4): 740-744
Terra, S.G.; Tsunoda, S.M. 1998: Opioid antagonists in the treatment of pruritus from cholestatic liver disease Annals of PharmacoTherapy 32(11): 1228-1230
Jones, E.A.; Bergasa, N.V. 1992: The pruritus of cholestasis and the opioid system JAMA 268(23): 3359-3362
Quigley, C. 1996: 5HT3 receptor antagonists and pruritus due to cholestasis Palliative Medicine 10(1): 54
Miller, J.L.; Hagemann, T.M. 2011: Use of pure opioid antagonists for management of opioid-induced pruritus American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 68(15): 1419-1425
Schumann, R.; Hudcova, J. 2004: Cholestasis of pregnancy, pruritus and 5-hydroxytryptamine 3 receptor antagonists Acta Obstetricia et Gynecologica Scandinavica 83(9): 861-862
Bergasa, N.V.; Jones, E.A. 1991: Management of the pruritus of cholestasis: potential role of opiate antagonists American Journal of Gastroenterology 86(10): 1404-1412
Lonsdale-Eccles, A.A.; Carmichael, A.J. 2009: Opioid antagonist for pruritus of cholestasis unmasking bony metastases Acta Dermato-Venereologica 89(1): 90
Jones, E.A.; Neuberger, J.; Bergasa, N.V. 2002: Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions Qjm: Monthly Journal of the Association of Physicians 95(8): 547-552
Jones, E.A.; Neuberger, J.; Bergasa, N.V. 2002: Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions Qjm (Oxford 1994. Print) 95(8): 547-552
Bergasa, N.V.; Thomas, D.A.; Vergalla, J.; Turner, M.L.; Jones, E.A. 1993: Plasma from patients with the pruritus of cholestasis induced opioid receptor-mediated scratching in monkeys Life Sciences (1973) 53(16): 1253-1257
Bergasa, N.V.; Thomas, D.A.; Vergalla, J.; Turner, M.L.; Jones, E.A. 1993: Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys Life Sciences 53(16): 1253-1257
Kwatra, S.G.; Ständer, S.; Kang, H. 2019: More on Mu-Opioid Receptor Antagonists in PD-1 Blockade-Induced Pruritus New England Journal of Medicine 380(6): 602
Kyriakides, K.; Hussain, S. K.; Hobbs, G. J. 2000: Management of Opioid-Induced Pruritus: A Role for 5-HT3 Antagonists? Survey of Anesthesiology 44(1): 41-42
Balak, D.M.W.; Hajdarbegovic, E. 2019: More on Mu-Opioid Receptor Antagonists in PD-1 Blockade–Induced Pruritus New England Journal of Medicine 380(6): 601
Kyriakides, K.; Hussain, S.K.; Hobbs, G.J. 1999: Management of opioid-induced pruritus: a role for 5-HT3 antagonists? British Journal of Anaesthesia 82(3): 439-441